568556-28-5

Basic information

• Product Name: 3-methoxy-4-(2-methyl-5-oxazolyl)benzenamine
• Synonyms: 3-methoxy-4-(2-methyl-5-oxazolyl)benzenamine;3-methoxy-4-(2-methyloxazol-5-yl)benzenamine
• CAS NO: 568556-28-5
• Molecular Formula: C₁₁H₁₂N₂O₂
• Molecular Weight: 204.22518
• Mol File: 568556-28-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-methoxy-4-(2-methyl-5-oxazolyl)benzenamine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-methoxy-4-(2-methyl-5-oxazolyl)benzenamine(568556-28-5)
• EPA Substance Registry System: 3-methoxy-4-(2-methyl-5-oxazolyl)benzenamine(568556-28-5)

Safety Data

• Hazardous Substances Data: 568556-28-5(Hazardous Substances Data)

Usage

Common uses

Building block for the synthesis of pharmaceuticals and agricultural chemicals

Structural features

Possesses a methoxy group, a methyl group, and an oxazolyl group attached to a benzene ring

Versatile intermediate

Suitable for various chemical reactions

Medicinal properties

Potential for the development of new drugs for the treatment of various diseases

Utilization in biotechnology and organic synthesis

Valued for its unique structure and reactivity

Upstream product

• 90564-14-0 1-(2-methoxy-4-nitrophenyl)ethanone 
• 568556-27-4 Acetic acid (Z)-2-azido-1-(2-methoxy-4-nitro-phenyl)-vinyl ester 
• 678970-10-0 2-azido-1-(2-methoxy-4-nitro-phenyl)-ethanone 
• 678970-09-7 1-(1-ethoxy-vinyl)-2-methoxy-4-nitro-benzene 
• 568556-26-3 2-bromo-1-(2-methoxy-4-nitro-phenyl)-ethanone 
• 77337-82-7 1-bromo-2-methoxy-4-nitrobenzene 
• 99985-27-0 5-(2-methoxy-4-nitro-phenyl)-2-methyl-oxazole 

Downstream Products

• 1452227-34-7 C₂₃H₂₆N₆O₄ 
• 1239717-52-2 C₂₄H₂₀FN₅O₂ 
• 1239720-15-0 C₂₉H₂₃F₃N₄O₃ 
• 1239717-35-1 C₂₄H₁₉FN₄O₂ 
• 1185018-11-4 (4-benzyl-6-methyl-pyrimidin-2-yl)-[3-methoxy-4-(2-methyl-oxazol-5-yl)-phenyl]-amine 

Relevant articles and documents

NOVEL SUBSTITUTED TRIAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS

The present invention is concerned with novel substituted triazole derivatives of Formula (I) wherein Het1, R1, R2, A1, A2, A3, A4, L1, and L2 have the mean

NOVEL SUBSTITUTED TRIAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS

The present invention is concerned with novel substituted triazole derivatives of Formula (I) wherein Het1, R1, R2, A1, A2, A3, A4, L1, and L2 have the meaning defined in the claims. The compounds according to the present invention are useful as gamma sec

NOVEL SUBSTITUTED BICYCLIC TRIAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS

The present invention is concerned with novel substituted bicyclic triazole derivatives of Formula (I) wherein Het1, R1, R2, A1, A2, A3, A4, L1, and L2 have the meaning defined in the claims. The compounds according to the present invention are useful as gamma secretase modulators. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

NOVEL SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS GAMMA SECRETASE MODULATORS

The present invention is concerned with substituted bicyclic heterocyclic compounds of Formula (I) wherein Het1, Het2, A1, A2, A3 and A4 have the meaning defined in the claims. The compounds according to the present invention are useful as gamma secretase modulators. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

NOVEL SUBSTITUTED INDAZOLE AND AZA-INDAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS

The present invention is concerned with novel substituted indazole and aza-indazole derivatives of Formula (I), wherein R1, R2, R3, R4, Y, A1, A2, A3, A4, X1, X2, X3 and Het1 have the meaning defined in the claims. The compounds according to the present invention are useful as gamma secretase modulators. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Inhibitors of inosine monophosphate dehydrogenase: SARs about the N-[3-methoxy-4-(5-oxazolyl)phenyl moiety

The first reported structure-activity relationships (SARs) about the N-[3-methoxy-4-(5-oxazolyl)phenyl moiety for a series of recently disclosed inosine monophosphate dehydrogenase (IMPDH) inhibitors are described. The syntheses and in vitro inhibitory values for IMPDH II, and T-cell proliferation (for select analogues) are given.